Further work should determine whether these discrepancies stem from interspecies differences or whether they reflect different immune responses to diverse cancer types (e.g., LLT1-expressing lymphoma controlled by NK cells and solid tumor mostly controlled by T cells). Here, CLEC2D is linked to cancer.